Advance Science & Medicine by Connecting Patients to Life-Saving Therapeutics

📨 Email dave@doubleblindbio.co to apply

<aside> 💡

Why Double Blind Bio (DBB)?

We Accelerate the Development of Next Generation Medicines

• We work directly with Clinical Research Sites, Sponsors and Clinical Research Organizations (CROs) to embed our technology to accelerate clinical trials.

We move fast

• We went from initial idea to product in customer’s hands in three weeks. In our first six months, we onboarded 200 research sites, landed our first pharma design partner and our existing lead investors, SignalFire (Uber, Grammarly, Lime, Ro, Aura) and Define Ventures (hims & hers, Story Health) doubled down on their investment in us.

Work with Life Sciences Experts

• The founders, Shruti (CEO) and Dave (CTO), have spent their careers working at the intersection of Life Sciences/Healthcare, Data, and AI on both business development and technology in both large organizations and startups. Our team is comprised of operators from life sciences and health technology

</aside>

About Us

Double Blind Bio automates administrative tasks, allowing clinical staff to focus on what matters most: patient care and advancing science. We’re building a future where clinical trials operate more autonomously by connecting sites, sponsors, and their data using AI. Our mission is to accelerate the delivery of cutting-edge therapeutics from development to market by building intelligent software that streamlines clinical trial operations.

To date, we’ve raised over $7 million in funding from our co-lead investors, SignalFire and Define Ventures, to accelerate this vision. Currently, we’re used by over 200 clinical research sites and have a handful of sponsor customers.

The Vision

We exist to accelerate scientific development and improve human well-being by increasing the efficacy of medicines worldwide. Today, bringing a drug to market takes over 10 years and $1-2 billion, with clinical trials consuming the bulk of the time and resources, not drug discovery.

Imagine if you could cut the time and/or cost of running a clinical trial in half. According to the Jevons paradox, as costs drop, demand for running clinical trials would rise, allowing more candidate therapies and more niche treatments to be tested and to reach the market. Clinical trial operations sit at the center of this and are the problem Double Blind Bio is solving for.

The Opportunity

You’ll be our first designer, shaping the product experience from the ground up. You’ll work directly with Dave (CTO) and the founding engineering team on the end-to-end lifecycle of products and features, from user interviews to feature reviews before they ship to customers. You’ll also work with Shruti on marketing material, branding, and other company visuals.

Customers already rave about our product's design, and we see it as a competitive edge. Help us take it to the next level.

What You’ll Do

• Help us build site and sponsor love for our products
• Work with the founding team on product, marketing, engineering to craft impactful experiences
• Own the end-to-end design process: research, wireframes, prototypes, high-fidelity UI, and working with engineers to ship
• Elevate design culture through remarkable quality and consistent work
• Shape the product roadmap alongside founding team

Who You Are

• 4+ years designing digital products, ideally in B2B SaaS